Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas
NCT02205788 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-07-10
Summary
The purpose of this study is to determine if you can use an assay on tumor samples to see different patterns in response to the same chemotherapy treatment.
Conditions
Sponsors & Collaborators
-
Patrick Joseph Loehrer Sr.
lead OTHER
Principal Investigators
-
Bert O'Neil, MD · Indiana University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2016-09-14
- Completion
- 2016-09-14
More Related Trials
-
Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
NCT00012220 ·Status: COMPLETED ·Phase: PHASE2
-
Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer
NCT02283372 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer
NCT02570711 ·Status: TERMINATED ·Phase: PHASE2
-
Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma
NCT02391662 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
NCT02318095 ·Status: COMPLETED ·Phase: NA
-
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
NCT06600906 ·Status: RECRUITING
-
Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
NCT02358161 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma
NCT03915444 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
NCT02902484 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo
NCT02496832 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer
NCT02017015 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma
NCT06229496 ·Status: RECRUITING ·Phase: PHASE1
-
Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer
NCT02685228 ·Status: UNKNOWN ·Phase: NA
-
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
NCT00805688 ·Status: COMPLETED
-
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
NCT00767273 ·Status: COMPLETED ·Phase: NA
-
A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer
NCT02210559 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
NCT07026981 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
NCT04665947 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT05825066 ·Status: RECRUITING ·Phase: PHASE2
-
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
NCT04233866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
NCT01851174 ·Status: TERMINATED ·Phase: PHASE2
-
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer
NCT04975516 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
NCT06849063 ·Status: RECRUITING
-
Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma
NCT04565327 ·Status: TERMINATED ·Phase: PHASE2
-
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
NCT00320749 ·Status: COMPLETED ·Phase: PHASE1